Canvas Wealth Advisors LLC Has $4 Million Holdings in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Canvas Wealth Advisors LLC trimmed its stake in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) by 17.9% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 268,037 shares of the medical instruments supplier's stock after selling 58,261 shares during the period. DENTSPLY SIRONA comprises about 1.0% of Canvas Wealth Advisors LLC's portfolio, making the stock its 25th largest position. Canvas Wealth Advisors LLC owned about 0.13% of DENTSPLY SIRONA worth $4,004,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors have also made changes to their positions in the stock. Lecap Asset Management Ltd. acquired a new stake in DENTSPLY SIRONA in the 1st quarter valued at approximately $761,000. Blue Trust Inc. grew its stake in shares of DENTSPLY SIRONA by 57.7% during the 1st quarter. Blue Trust Inc. now owns 12,554 shares of the medical instruments supplier's stock worth $188,000 after acquiring an additional 4,595 shares in the last quarter. Janney Montgomery Scott LLC grew its stake in shares of DENTSPLY SIRONA by 210.5% during the 1st quarter. Janney Montgomery Scott LLC now owns 64,191 shares of the medical instruments supplier's stock worth $959,000 after acquiring an additional 43,516 shares in the last quarter. Hanson & Doremus Investment Management acquired a new stake in shares of DENTSPLY SIRONA in the first quarter valued at approximately $90,000. Finally, Sound Income Strategies LLC lifted its position in shares of DENTSPLY SIRONA by 43.7% in the first quarter. Sound Income Strategies LLC now owns 347,841 shares of the medical instruments supplier's stock worth $5,197,000 after purchasing an additional 105,777 shares in the last quarter. 95.70% of the stock is currently owned by institutional investors and hedge funds.

DENTSPLY SIRONA Price Performance

Shares of DENTSPLY SIRONA stock opened at $16.00 on Friday. The company has a debt-to-equity ratio of 0.79, a quick ratio of 0.76 and a current ratio of 1.10. The stock has a market capitalization of $3.19 billion, a price-to-earnings ratio of -3.52, a P/E/G ratio of 1.14 and a beta of 0.95. The company's 50 day moving average price is $15.33 and its 200-day moving average price is $16.62. DENTSPLY SIRONA Inc. has a 52-week low of $12.16 and a 52-week high of $27.95.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last posted its earnings results on Thursday, May 8th. The medical instruments supplier reported $0.43 earnings per share for the quarter, beating analysts' consensus estimates of $0.29 by $0.14. DENTSPLY SIRONA had a positive return on equity of 14.31% and a negative net margin of 24.42%. The company had revenue of $879.00 million for the quarter, compared to the consensus estimate of $854.75 million. During the same quarter in the prior year, the company earned $0.42 earnings per share. DENTSPLY SIRONA's revenue was down 7.8% on a year-over-year basis. Equities research analysts forecast that DENTSPLY SIRONA Inc. will post 1.84 EPS for the current year.

DENTSPLY SIRONA Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, July 11th. Stockholders of record on Friday, June 27th will be issued a $0.16 dividend. This represents a $0.64 dividend on an annualized basis and a dividend yield of 4.00%. The ex-dividend date of this dividend is Friday, June 27th. DENTSPLY SIRONA's dividend payout ratio (DPR) is -14.10%.

Analyst Ratings Changes

Several equities research analysts have issued reports on XRAY shares. Wall Street Zen upgraded shares of DENTSPLY SIRONA from a "hold" rating to a "buy" rating in a research note on Friday, May 9th. Mizuho decreased their price objective on DENTSPLY SIRONA from $21.00 to $18.00 and set a "neutral" rating for the company in a report on Thursday, March 13th. Wells Fargo & Company lowered their target price on DENTSPLY SIRONA from $20.00 to $19.00 and set an "equal weight" rating on the stock in a research report on Friday, February 28th. Needham & Company LLC reissued a "hold" rating on shares of DENTSPLY SIRONA in a research note on Thursday, March 13th. Finally, Piper Sandler decreased their price objective on shares of DENTSPLY SIRONA from $20.00 to $16.00 and set a "neutral" rating for the company in a research report on Wednesday, April 30th. Eleven analysts have rated the stock with a hold rating and three have given a buy rating to the stock. According to MarketBeat, the stock currently has a consensus rating of "Hold" and a consensus price target of $20.36.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.